Sovremennye printsipy terapii gonokokkovoy infektsii


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article discusses the choice of treatment of gonococcal infection taking into account the antibiotic resistance of the pathogen of the disease, Neisseria gonorrhoeae. Current parameters of sensitivity of microorganisms to antibiotics in the world and in the Russian Federation are presented. The application of the oral preparation of III generation cephalosporin - cefixime (Pancef) in the treatment of gonococcal infections is justified. The basic pharmacokinetic characteristics and advantages of cefixime are discussed. The schemes of treatment of gonococcal infection according to the Federal clinical guidelines of the Russian Society of dermatologists and cosmetologists are presented.

Full Text

Restricted Access

About the authors

M. R Rakhmatulina

Email: 79096405611@yandex.ru

References

  1. Рахматулина М.Р., Соколовский Е.В., Фриго Н.В. Российское общество дерматовенерологов и косметологов. Федеральные клинические рекомендации по ведению больных гонококковой инфекцией (Национальные клинические рекомендации) http://193.232.7.120/feml/clinical_ ref/0001371449S/HTML/#1
  2. Рахматулина М.Р., Барышков К.В., Абудуев Н.К Особенности клинических проявлений гонококковой инфекции и тактика терапии заболевания с учетом антибиотикочувствительности N. gonorrhoeae в Архангельской области. Вестник дерматологии и венерологии. 2014;(6): 100-06.
  3. Kirkcaldy R.D., Zaidi A., Hook E.W., et al. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010. Annals International Medicine. 2013;158(5 Pt 1):321-28.
  4. Goire N., Ohnishi M., Limnios A.E., Lahra M.M., Lambert S.B., Nimmo G.R., Nissen M.D., Sloots T.P., Whiley D.M. Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: a real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain. Journal Antimicrob. Chemother. 2012;67:902-05.
  5. Wang S.A., Lee M.V., O'Connor N., Iverson C.J., Ohye R.G., Whiticar P.M., Hale J.A., Trees D.L., Knapp J.S., Effle rP.V., Weinstock H.S. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime - Hawaii. Clin. Infect. Dis. 2003;37(6):849-52.
  6. Bignell C., Unemo M. European Guideline on the Diagnoses and Treatment of Gonorrhoeae in Adults. Available at: http://www.iusti.org/ regions/Europe/pdf/2012/Gonorrhoea_ 2012.pdf.
  7. CDC. Sexually Transmitted Diseases Surveillance 2012. Atlanta: US Department of Health and Human Services; 2015; available at: http://www.cdc.gov/std/tg2015/ gonorrhea.htm
  8. Brocklehurst P. Antibiotics for gonorrhoea in pregnancy Cochrane Database Syst. Rev. 2000;(2):CD000098.
  9. Hay J. Complications at site of injection of depot neuroleptics. BMJ. 1995;311(7002):421.
  10. Lee J.H., Girffiths W.J., Bottomley R.H. Extraosseous osteogenic sarcoma following an intramuscular injection. Cancer. 1977;40(6):3097-101.
  11. Weinbren K., Salm R., Greenberg G. Intramuscular injections of iron compounds and oncogenesis in man. Br. Med. J. 1978;1(6114):683-85.
  12. Cockburn J., Reid A.L., Bowman J.A., Sanson-Fisher R.W. Effects of intervention on antibiotic compliance in patients in general practice. Med. J. Austral. 1987;147(7): 324-28.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies